People

Patient and Public Involvement (PPI) is central at King’s CICM. We will listen to, collaborate with, and strive to serve the needs of patients and society.

We aspire to establish King’s CICM as:

  • A strategic centre nurturing ICM talents and advancing innovation, including innovation in medical humanities and technologies, through research of excellence supported by philanthropic funding and other funding resources.
  • A dynamic hub for exchange, collaboration and innovation among our
    • Staff, with expertise in studies of Ageing, AI and Digital Technologies, Cancer, Cardiology and Vascular Biology, Clinical Studies, ICM, Medical Humanities, Medical Statistics, Medicinal Chemistry, Nephrology, Pharmaceutical Science, PPI and, of course, Fundraising — our expertise and research remit will grow as the King’s CICM initiative develops;
    • Honorary Advisors with complementary expertise in Acupuncture & TCM, Chinese Materia Medica and Herbal Medicine, Clinical Trial Design and Medical Statistics, Pharmacy, Pharmacognosy, Pharmacology, and PPI — our Honorary Advisors are international and national (UK) leaders of the TCM community and related studies.
      • Given China’s vast expertise and unique leadership in TCM and relevant studies, we risk honouring a few but missing many if we choose to appoint Honorary Advisors from Mainland China; to avoid this, we refrain from appointing Honorary Advisors from Mainland China (except for those playing leading roles at international societies, especially GP-TCM RA). Instead, we look forward to developing pragmatic collaborations and strive to be their preferred British collaborators.
    • Collaborators and Partners: From King’s CICM Fora, Website, Studies of Classic and Contemporary TCM Literature, to Clinical and Preclinical Research Projects, we will develop interregional, interdisciplinary and inter-sectoral partnerships tailored to the needs of specific projects. This evolving collaborative ecosystem constitutes a defining feature of King’s CICM and serves as a fundamental pillar of our success, with its scope and impact growing in tandem with project advancement.

For each project, we shall appoint a steering committee to advise on quality control. This committee will be selected from Staff, Honorary Advisors, Collaborators and Stakeholders, depending on the needs of specific projects.

Directorship

Director (overall leadership)

Dr. Qihe Xu
(Click photo for CV, CICM Edition)

Co-Director (leading AI, big data and clinical research)

Prof. Yanzhong Wang
(Click photo for CV, CICM Edition)

Assistant Director (internal organisation and coordination)

Portrait of a man wearing glasses and a beige blazer, with a light blue shirt underneath, smiling slightly against a background of blurred reception area.
Dr. Min Zhang
(Click photo for CV, CICM Edition)

R&D Programmes

Cardiovascular, Kidney and Metabolic Health

  • Prof. Luigi Gnudi: Professor of Diabetes and Metabolic Medicine/ Consultant in Diabetes and Endocrinology; Head, Unit for Metabolic Medicine, School of Cardiovascular and Metabolic Medicine & Sciences, FoLSM, King’s College London. Expert in Diabetes and diabetic nephropathy. Research interests are:
    • Preventing and treating chronic diabetic cardiovascular and renal complications through an integrative medicine approach (e.g.,  new target for treatment; new molecules/compounds).
    • Study mechanisms of vascular diseases and treatment through new therapeutic targets, e.g., studying new compounds/molecules.
    • Using randomised clinical trials to evaluate integrative medicine, particularly for preventing and treating diabetes, its chronic cardiovascular and renal complications.  
  • Dr Haotian Gu (顾昊天): Clinical Senior Lecturer, FoLSM, King’s College London; Honorary Consultant Clinical Scientist in Cardiac Imaging at St Thomas’ Hospital. Research interests are:
    • Cardiac imaging and clinical research
    • AI application in cardiac imaging
  • Prof Iain Macdougall: ex-Professor of Clinical Nephrology, King’s College Hospital (retired). Expert in Randomised clinical trials (>30 NEJM, Lancet, JAMA and BMJ papers, Hi-index 94). Research interest focuses on
    • Using randomised clinical trials to evaluate integrative medicine, particularly for preventing and treating kidney diseases.
  • Dr Richard Siow: Director, Ageing Research at King’s and Reader in Vascular Biology, FoLSM, King’s College London. Expert in Ageing; Visiting Professor of the University of Oxford, Healthy Longevity and Preventive Medicine Research
    • TCM and integrative medicine treatment of kidney diseases, esp. membranous nephropathy.
    • Understanding of kidney defence mechanisms and its role as a new intervention target
  • Dr Qihe Xu (徐啟河): Director, King’s CICM; Senior Lecturer in Renal Medicine & Pharmacology, King’s College London; Board Member and Co-Chair of the Pharmacology & Toxicology Interest Group, Good Practice in Traditional Chinese Medicine Research Association (GP-TCM RA). Co-Chair, Consortium for Globalization of Chinese Medicine UK Branch. Research directions are:
    • TCM literature research: Cataloguing and analysing TCM collections of major UK institutions, to support TCM research, education and practice.
    • TCM-inspired biological insights: Guided by TCM’s Zhengqi and Yangqi concepts, to elucidate renal defence and intracellular metabolic mechanisms and their dysregulation in kidney disease.
    • TCM-inspired therapeutic development: Focusing on tonifying herbs and therapies targeting the vitamin A signalling pathway, to develop novel strategies for the prevention and treatment of kidney disease.
    • TCM diagnostics and non-pharmacological therapies: Biomedical research and evidence-based integration into NHS clinical service and care.
  • Dr Min Zhang (張敏): Assistant Director of King’s Centre for Integrative Chinese Medicine; Senior Lecturer in Cardiovascular Biology, FoLSM, King’s College London. Research interests are:
    • Integrative mediciine for heart disease
    • Development of herbal medicines and natural compounds as therapeutics for heart disease
    • Coordination of fundamental and translational research at King’s CICM
  • Dr Qiuping Zhang (張秋萍): Senior Lecturer in Cardiovascular Biology, FoLSM, King’s College London. Vascular Research Expert. Research interests are:
    • Nesprins have emerged as potential therapeutic targets because of their essential roles in nuclear–cytoskeletal coupling and cellular mechanotransduction. Dysregulation or mutation of nesprins has been implicated in vascular diseases, cardiomyopathies, muscular dystrophies, certain cancers, and progeroid syndromes.
    • Development of herbal medicines and natural compounds, particularly those derived from traditional Chinese medicine, as novel therapeutics, for example by modulating pathways involving nesprins.  

Visiting staff

  • Prof. Wuquan Deng, Visiting Senior Research Fellow, King’s College London; Vice President, Consultatnt Physician and Professor of Endocrinology and Metabolic Health, Chongqing Central Hospital Affiliated to Chongqing University, Chongqing, China. Research interests:
    • Pathogenesis of diabetes and its complications
    • Advancing prevention and treatment of diabetic foot wounds
  • Dr Xinhui Wang, Visiting Postdoctoral Fellow, King’s College London; Attending TCM Physician, Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Research interests:
    • TCM and integrative medicine treatment of kidney diseases, esp. membranous nephropathy.
    • Understanding of kidney defence mechanisms and its role as a new intervention target

Cancer and Pharmaceutical Sciences

  • Prof Khuloud Al-Jamal: Professor of Drug Delivery & Nanomedicine and Head of Medicines Development, FoLSM, King’s College London; Head of Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong.
    • Leading KCL-HKU Liaison.
  • Ms Mandy Brass: MSc MBAcC, Lead Acupuncturist at Dimbleby Cancer Care, Guy’s Cancer Centre, Guy’s and St Thomas’ NHS Foundation Trust. Research interest:
    • Acupuncture for cancer patients, especially those with multiple long-term conditions.
  • Prof Miraz Rahman: Professor of Medicinal Chemistry, FoLSM, King’s College London. Research interest:
    • Antimicrobial & Anticancer Drug Discovery
  • Prof Eric CW So: King’s CICM Cancer Research Theme Lead. Professor and Chair in Leukaemia Biology, FoLSM, King’s College London. 
    • Cancer Research Theme Lead
    • Leukaemia and Stem Cell Biology Research.

Medical Statistics, AI and Digital Technology

  • Prof Yanzhong Wang (王岩中): Co-Director of King’s Centre for Integrative Chinese Medicine; Professor of Statistics in Population Health, Head of Medical Statistics, King’s College London.
    • Clinical trials
    • Big data research
    • AI application in integrative medicine
  • Dr Zhiqiang Huo (霍志強): Visiting Lecturer, KCL; Lecturer, Queen Mary University of London. Expert in AI and digital technologies in health. Research interests:
    • Medical Big Data Analysis used for disease prevalence, diagnosis and prognosis;
    • Cardiometabolic disease prevention using advanced machine learning and electronic health record analysis;
    • Chronic disease management using digital health technology and wearables;
    • Co-production of digital health technology using AI, digital health and co-design approaches with healthcare stakeholders.

Medical Humanities

  • Prof Fay Bound Alberti: Professor and Director, Centre for Technology and the Body, Professor in Modern History, King’s College London. Research interests:
    • Sociology, anthropology, literary and gender aspects of integrative medicine
    • Medical humanities
  • Prof Chris Berry: Professor of Film Studies, Expert in Arts and Media Research; The CICM Liaison with the Faculty of Arts & Humanities. Research interests include:
    • Traditional Chinese Medicine in Film
    • Documentary Film in Medicine, Especially Traditional Chinese Medicine and Integrative Medicine.

Visiting staff

  • Mr Jun Luo, PhD candidate. Visiting Research Fellow, King’s College London; Lecturer and Head of the Office of Scientific Management, School of Chinese Classics, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Research interests:
    • Translation and communications;
    • Medical history & TCM literature.

Psychiatry, Psychology and Neuroscience

  • Prof. Dag Aarsland: Professor of Old Age Psychiatry; Co-Director of Ageing Research at King’s; Director of Centre for Healthy Brain Ageing and Director of NIHR HealthTech Research Centre in Brain Health, Institute of Psychiatry, Psychology & Neuroscience, King’s College London. Expertise: Consultant Old Age Psychiatrist, Dementias, Digital Health, Clinical Trials. Research Interests:
    • Alzheimer’s Disease; Blood and CSF Biomarkers; Care Homes; Healthy Brain Ageing.
  • Dr Po-Wah So: Reader in Biomedical Imaging and Spectroscopy; Head, Phenomics Lab | Departmental Admissions Tutor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, KCL; expert in biomedical imaging, spectroscopy, phenomics, ageing and Alzheimer’s Disease. Main research interests:
    • Metal Biology, Especially Iron, in Brain Ageing and Alzheimer’s Disease: Dr So investigates how iron and other biologically active metals regulate brain microstructure, oxidative stress, neuroinflammation, and vulnerability during ageing. Her work defines metal-driven mechanisms, including ferroptosis-induced cell death and its role in Alzheimer’s Disease pathology.
    • Obesity and Fatty Liver Disease; Systemic Metabolic and Inflammatory Dysregulation and Its Impact on the Brain: Dr So has been, and continues to be, deeply engaged in studying metabolic diseases such as obesity and fatty liver disease to understand how systemic metabolic stress and inflammation affect whole-body physiology and impair brain function. This approach reflects TCM principles that disturbances in nourishment, fluid balance, and organ harmony propagate to the brain and influence cognitive health.
    • Innovation in Multimodal Imaging and Spectroscopy: Dr So advances quantitative MRI by identifying the biological and metal substrates that contribute to multimodal quantitative MRI signals. Beyond magnetic resonance-based imaging and spectroscopy methods including NMR-based metabolomics, she advances the use of bulk and spatial elemental analyses of tissue (elementomics/metallomics) as well as emerging photoacoustic and Raman technologies. This multimodal strategy drives next-generation of imaging and spectroscopy tools in biomedical research, resonating with TCM tradition of integrating diverse diagnostic modalities.

Visiting staff

  • Dr. Mo Li, Visiting Professor, King’s College London; Chief Physician, Beijing Geriatric Hospital, China. Dr Li specialises in geriatric psychiatry, cognitive impairment, and Alzheimer’s disease (AD), especially integrating traditional Chinese medicine (TCM), artificial intelligence (AI), and modern neuroscience. Her research focuses on identifying pathological and behavioural biomarkers, constructing predictive models for disease progression, and developing non-pharmacological interventions to improve cognitive function and quality of life in older adults. Research interests:
    • Integrative medicine (TCM and modern neuroscience) for cognitive impairment and AD
    • AI-driven digital biomarkers and multimodal assessment for neurodegenerative diseases
    • Non-pharmacological interventions and rehabilitation for geriatric cognitive disorders

Central Support

Fundraising

  • Mr David Meredith: Associate Director, Principal & International Giving, King’s College London.
  • Ms Mylen Namocatcat, Head of Philanthropy International, King’s College London.
  • Mr Oliver Mangham: Senior Philanthropy Manager – International, King’s College London.
  • Mr Alex Page: Senior Donor Relations Manager, Philanthropy & Alumni Engagement, King’s College London and King’s Maudsley Partnership.

Acupuncture and TCM

  • Ms Mandy Brass: MSc MBAcC, Lead Acupuncturist at Dimbleby Cancer Care, Guy’s Cancer Centre, Guy’s and St Thomas’ NHS Foundation Trust.
    • Acupuncture for cancer patients, especially those with multiple long-term conditions.
  • Ms Titta M. Laattala: Lic.TCM, Dip.MQG, Dip.CHM, MPRTCM, MPRCHM, MRCHM, King’s College Health Centre, King’s College London; Board Member, Treasurer & Finance Officer, Register of Chinese Herbal Medicine, UK. Main research interests:
    • Tongue and Pulse in TCM diagnostics: How it is affected by dAcupuncture for cancer patients, especially those with multiple long-term conditions.ifferent interventions, including different classes of pharmaceutical drugs
    • Effectiveness of Chinese herbal medicine in the treatment of chronic skin conditions
    • Effects of Medical Qigong Fa Qi on brain function

Laboratory Management and Technical Support

  • Mr Mazhar Noor: Technical Manager, Department of Inflammation Biology, FoLSM, King’s College London. Research interests:
    • Renal Cell Biology
    • Animal Models of Kidney Diseases

Patient and Public Involvement (PPI) Advisor

Equality, Diversity & Inclusion (EDI) Representative; Bioimaging and Phenomics Advisor

  • Dr Po-Wah So: Details in the Psychiatry, Psychology and Neuroscience section

Prof Tommy Yung-Chi Cheng (鄭永奇)
Chairman, The Consortium for Globalization of Chinese Medicine (CGCM); Henry Bronson Professor of Pharmacology, Yale University, New Haven, USA.

Prof Clara Bik-San Lau (劉碧珊)
Past President and Board Member, GP-TCM RA and Secretary-General of CGCM; Professor, Department of Pharmacology and Pharmacy, and School of Chinese Medicine; Associate Director (Research), HKUMed Centre of Integrative Medicine, The University of Hong Kong; Past President, GP-TCM RA; Secretary-General, CGCM, The University of Hong Kong, Hong Kong, China.

Board members

Prof Zanyu Chen (陳贊育)
President of the Federation of Traditional Chinese Medicine Practitioners, UK; Professor, Phoenix Academy of Acupuncture & Herbal Medicine; Chief editor of the Journal of Chinese Medicine in the UK.

Prof Yibin Feng (冯奕斌)
Professor and Director, School of Chinese Medicine, The University of Hong Kong, Hong Kong SAR, China.

Mr Alex Jacobs
CEO, The British Acupuncture Council, UK.

Prof Dan Jiang (江丹)
Professor of Phoenix Academy of Acupuncture & Herbal Medicine; Senior TCM practitioner, Acu-Herb Consultant Sheffield, UK. Elected as one of the 22 Overseas TCM Grand Masters worldwide in 2024.

Mr Martin John
President, Register of Chinese Herbal Medicine (RCHM), UK.

Prof Songxuan Ke (柯松軒)
Principal and Professor, Asante Academy of Chinese Medicine, UK; President, British Society of Chinese Medicine

Prof Zhixiu Lin (林志秀)
Professor and Director, School of Chinese Medicine, The Chinese University of Hong Kong, China; Director, Hong Kong Institute of Integrative Medicine.

Prof Xin Lu (鹿馨)
Senior TCM practitioner, UK; Professor, UK Academy of Chinese Medicine; Executive-President, World Traditional Medicine Forum

Prof Aiping Lyu (呂愛平)
Professor in Chinese Medicine; Former President of the GP-TCM RA; Vice-President (R&D), the Hong Kong Baptist University; Dean of Graduate School and Acting Dean of the School of Chinese Medicine of the Hong Kong Baptist University, Hong Kong, China

Prof Nicola Robinson
Emeritus Professor of Traditional Chinese Medicine and Integrated Health, London South Bank University, UK; Visiting Professor Centre for Evidence-based Chinese medicine, Beijing University of Chinese medicine; Honorary Editor-in-Chief, European Journal of Integrative Medicine; Founding Board Member, GP-TCM RA.

Prof Jiangang Shen (沈劍剛)
Professor, School of Chinese Medicine, The University of Hong Kong, China.

Prof Shulan Tang (湯淑蘭)
Principal, Shulan College of Chinese Medicine, Manchester, UK; Vice President of the World Federation of Chinese Medicine Societies Gynaecology committee.

Dr Tiejun Tang (唐鐵軍)
President, Chinese Medicine Alliance UK; Vice Chairman of the World Traditional Medicine Forum. In 2024, elected as one of the 22 Overseas TCM Grand Masters worldwide.

Dr Tianjun Wang (王天俊)
Principal, London Academy of Chinese Acupuncture, UK; Honorary President of Chinese Acupuncture and Herbal Medicine Alliance UK; Guest Professor of Nanjing University of Chinese Medicine; Director of TJ Acupuncture Ltd; President of the Academy of Scalp Acupuncture UK; Chairman of the UK TCM Forum.

Dr Jidong Wu (吳繼東)
Senior Acupuncturist and TCM Practitioner, Cambridge Chinese Medicine, UK; Member of the Herbal Medicine Advisory Committee of the Medicines and Healthcare products Regulatory Agency (MHRA), UK.

Dr Mei Xing (邢玫)
President, The Association of Traditional Chinese Medicine and Acupuncture, UK; Vice-President, World Federation of AcupunctureMoxibustion Societies).

Prof Guanhu Yang (楊觀虎)
Professor of Chinese Medicine, Faculty of Chinese Medicine, Macu University of Science and Technology; Deputy Editor-in-chief, New England Journal of Chinese Medicine.

Dr Liuzhong Ye (叶柳忠)
President, Chinese Acupuncture and Herbal Medicine Alliance, UK.

Prof Hongchun Yin (殷鸿春)
Senior TCM Practitioner; Founder of Modern Tongue Diagnostics; President, International Society of Modern Tongue Diagnostics; Dean, International College of Modern Tongue Diagnostics; Professor, British Danhuang Academy; Editorial Board Member, Journal of Chinese Medicine in the UK.

Dr Bing-Sheng Yuan (袁炳勝)
Vice-President, Federation of Traditional Chinese Medicine Practitioners, UK.

Dr Lian-Ting Zha0 (趙連廷)
Senior TCM Practitioner at Herbal China Health Beauty Clinic, London, UK; a specialist of the combination of Acupuncture with Medical Qigong.

Prof Liqin Zhao (趙麗琴)
Senior TCM Practitioner, Zhong Jing TCM UK, Sheffield, UK; Visiting professor of the Henan University of TCM, China;Former President, The Association of Traditional Chinese Medicine & Acupuncture; Co-Chairman of the World Congress of Reproductive Medicine and Executive Chairman of the Professional Committee of TCM (Reproduction); Vice President, Speciality Committee of Gynaecology, The World Federation of Chinese Medicine Societies; Vice President, Speciality Committee of Zhong Jing Academic Inheritance and Innovation, The World Federation of Chinese Medicine Society

Mr Abraham YL Chan (陳宇齡)
Board Member, GP-TCM RA; Chairman, CEO and Executive Director of PuraPharm Corporation; Board Member of the GP-TCM RA, International Society of Oriental Medicine (ISOM); founding director and former president of the Modernize Chinese Medicine International Association (MCMIA).

Mr George He (何朝華)
Co-Treasurer, GP-TCM RA; Executive Director of the UK Centre of Chinese Medicine; Managing Director of Phoenix Medical Group; Principal of Phoenix Academy of Acupuncture and Herbal Medicine, UK.

Prof Kelvin Chan
Emeritus Professor in Natural Products & TCM Research, Liverpool John Moores University, UK; Adjunct Professor in TCM Research at the National Institute of Complementary Medicine Health Research Institute of Western Sydney University, Australia; Visiting Professor at the Chengdu University of TCM, Chengdu, China; Founding Board Member, GP-TCM RA.

Prof Yuan Shiun Chang (張永勳)
Board Member, GP-TCM RA; Professor of Pharmacognosy, China Medical University, Taichung, Taiwan, China.

Dr Willow Liu
President, American Association of Chinese Herbs, USA.

Prof Monique Simmonds
OBE, Board Member and Former President, the GP-TCM RA; Director of Commercial Innovation Unit & Deputy Director of Science – Partnerships, Royal Botanic Gardens, Kew, UK.

Dr Mei Wang (王梅)
President and Board Member, GP-TCM RA; Founder and Chair, LU-European Center for Chinese Medicine and Natural Compounds, Institute of Biology, Leiden University, the Netherlands.

Dr Kaicun Zhao (趙凱存)

Member of the Expert Advisory Groups on herbal medicines for British Pharmacopeia Commission and Member of the Herbal Medicine Advisory Committee of MHRA, UK.

Prof Zhongzhen Zhao (趙中振)
Former Vice-Dean and Emeritus Professor, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China; In 2024, elected as one of the 22 Overseas TCM Grand Masters worldwide and the only one specialised in Chinese Materia Medica

Experts in Pharmacology and Pharmacognosy

Prof Rudolf Bauer (鮑儒德)
Board Member and Founding President of the GP-TCM RA; Former President of the Society for Medicinal Plant and Natural Products Research (GA) and the International Society for Ethnopharmacology (ISE); Chair, TCM Working Party of the European Pharmacopoeia; Emeritus Professor of Pharmacognosy, University of Graz, Austria.

Prof Tommy Yung-Chi Cheng (鄭永奇)
Chairman, The Consortium for Globalization of Chinese Medicine (CGCM); Henry Bronson Professor of Pharmacology, Yale University, New Haven, USA.

Prof Pierre Duez
Board Member of the GP-TCM RA; Emeritus Professor of Pharmacognosy, University of Mons, Belgium; member of the European Pharmacopoeia TCM working party, of the EMA, of the Belgian Commissions of Pharmacopoeia and Registration of Herbal Medicines.

Prof Thomas Efferth
Board Member, GP-TCM RA; Professor and Director, Institute of Pharmaceutical and Biomedical Sciences; Editor-in-Chief, Phytomedicine; Johannes Gutenberg University, Germany.

Prof Tai-Ping Fan (樊台平)
Treasurer, GP-TCM RA; Chair Professor, Shandong Academy of Sciences; Former Professor and Dean of School of Life & Health Sciences, Fuyao University of Science & Technology, China; Retired Head of Angiogenesis and Natural Product Laboratory, The University of Cambridge, UK.

Prof Michael Heinrich
President of the Society for Medicinal Plant and Natural Products Research (GA) and Former President of the International Society for Ethnopharmacology (ISE); Professor of Ethnopharmacology and Pharmacognosy, University College London, UK.

Prof Clara Bik-San Lau (劉碧珊)
Past President and Board Member, GP-TCM RA and Secretary-General of CGCM; Professor, Department of Pharmacology and Pharmacy, and School of Chinese Medicine; Associate Director (Research), HKUMed Centre of Integrative Medicine, The University of Hong Kong; Past President, GP-TCM RA; Secretary-General, CGCM, The University of Hong Kong, Hong Kong, China.

Prof Simon Ming-Yuen Lee (李銘源)
Past President and Board Member, GP-TCM RA; Secretary-General of the Consortium for Globalization of Chinese Medicine (CGCM); Professor in Phytomedicine, The University of Hong Kong, Hong Kong, China.

Prof Ge Lin (林鸽)
Professor, School of Biomedical Science, The Chinese University of Hong Kong, China.

Prof. Amala Soumyanath
Professor, Department of Neurology; Director, BENFRA Botanical Dietary Supplements Research Centre; Co-Director T32 CAM Research Training in Neuroscience and Stress, Oregon Health & Science University, Portland, OR, USA.

Prof Xuanbin Wang (汪選斌)
Board Member of the GP-TCM RA; Director of Hubei Key Laboratory of Wudang Local Chinese Medicine Research,  and Director of State Level-Three Laboratory NATCM, Department of Pharmacy, Renmin Hospital in Hubei University of Medicine, Shiyan, Hubei, China.

Dr Sukvinder Kaur Bhamra
Senior Lecturer in Clinical and Professional Practice, Medway School of Pharmacy, University of Kent, UK..

Prof Gerard Bodeker
Professor (retired), Division of Medical Sciences, University of Oxford; Adjunct Professor of Epidemiology at Columbia University, USA, and Adjunct Professor in Integrative Medicine at the University of Western Sydney, Australia.

Dr Cheng Soon Goh
Former Director of the Traditional and Complementary Medicine Division, Ministry of Health, Malaysia; Former Head of the WHO Collaborating Centre for Traditional, Complementary and Integrative Medicine; and Co-Chair of the 2nd WHO Global Traditional Medicine Summit steering committee.

Dr Xiaoyang Hu
Senior Research Fellow, University of Southampton, UK; Senior Advisor, NIHR Research Support Service; Co-Chair, Clinical Studies Interest Group, the GP-TCM RA.

Dr John Hughes
Director of Research, Royal London Hospital for Integrated Medicine, UCLH NHS Trust; Associate Professor, School of Medicine & Biosciences, University of West London, UK. https://www.uwl.ac.uk/staff/john-hughes

Dr Jeffrey B Kopp
Consulting Nephrologist, Former Chief, Kidney Disease Section, Kidney Diseases Branch, NIDDK, NIH, USA.

Dr Merlin Willcox
General Practitioner, Clinical Lecturer and Principal Research Fellow, University of Southampton, UK..

Prof Vivian T Wong (黃譚智媛)
JP, Board Member of the GP-TCM RA; Honorary Professor, LKS Faculty of Medicine, University of Hong Kong, China.

Prof Bin Yang (楊斌)
Senior Research Scientist, University Hospitals of Leicester; Honorary Professor in Renal Medicine, University of Leicester, UK.

Experts in Medical Humanity and PPI

Mr Shirong Chen (陳時榮)
Editor-in-chief, Templar Global Media; Managing Editor, Foremost 4 Media Limited, UK.

Financier, UK.

Prof Vivienne Lo (罗维前)
Professor, Department of History and the convenor of the UCL China Centre for Health and Humanity, University College London, UK.

Dr Hong Lu (盧紅)
OBE, Chairman, CEDP Chinese Centre (UK charity number 1118550), UK.

Prof Duolao Wang (王多勞)
Chair Professor in Biostatistics, Liverpool School of Tropical Medicine, UK.

Collaborators, at institutional, corporate and individual levels, will be continuously identified to match the needs of King’s and KHP Staff to drive progress together.

Examples of a few collaborating projects are as follows.

  • The Inaugural Forum of the King’s CICM Initiative 2.0 held on 5th January 2025
    • Financially enabled by an anonymous £1000 gift from an Honorary Advisor, and co-organised by the UK Centre of Chinese Medicine (King’s CICM Honorary Advisor Mr George He).
  • Developing and Updating the King’s CICM Website and Information Portal
    • Funded by a £3000 gift from Phoenix Medical Ltd (King’s CICM Honorary Advisor Mr George He) and advised by King’s Brand Marketing Officer Shana St Louis and KHP Fundraising Team members Mr Oliver Mangham and Mr Alex Page; spearheaded by Mr Yunfeng Wu (China-Britain Business Resources Limited) and supported by King’s CICM Honorary Advisors (esp. Ms Rosalyn Zhang and Dr Hong Lu) and MSc Research Assistant Ms Feitong Chen, and commented by all other King’s CICM Staff, Honorary Advisors and stakeholders.
  • Cataloguing, Curation and Investigation of the British Library TCM Literature
  • Scoping Review of International Standards and Good Practice Guidelines in Traditional, Complementary and Integrative Medicine, a GP-TCM RA Commission.
    • Spearheaded by King’s CICM Honorary Advisor Prof Xuanbin Wang, advised by King’s CICM Honorary Advisor Prof Pierre Dueez, and participated by GP-TCM RA Board members, Interest Group Leaders and other international experts.
  • Setting up the Peter Hylands, Peter Houghton, Boying Ma and Man Fong Mei Awards and the King’s CICM Fund.

As more pre-clinical, translational and clinical research projects unfold, we shall continue to highlight the collaborative nature of our work in this space. As Patient and Public Involvement (PPI) is central at King’s CICM, we’d love to hear from, collaborate with, and serve the needs of society. We welcome you to join our team!